A detailed history of Financial Management Network Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Management Network Inc holds 2,525 shares of ABBV stock, worth $449,475. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,525
Previous 2,391 5.6%
Holding current value
$449,475
Previous $410,000 21.46%
% of portfolio
0.12%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $21,954 - $26,710
134 Added 5.6%
2,525 $498,000
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $1,857 - $2,169
12 Added 0.5%
2,391 $410,000
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $1,917 - $2,185
12 Added 0.51%
2,379 $433,000
Q4 2023

Jan 22, 2024

BUY
$137.6 - $154.97 $688 - $774
5 Added 0.21%
2,367 $366,000
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $1,603 - $1,855
12 Added 0.51%
2,362 $352,000
Q2 2023

Jul 28, 2023

SELL
$132.51 - $164.9 $32,597 - $40,565
-246 Reduced 9.48%
2,350 $316,000
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $1,879 - $2,165
13 Added 0.5%
2,596 $413,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $1,521 - $1,824
11 Added 0.43%
2,583 $417,000
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $4,160 - $4,771
31 Added 1.22%
2,572 $365,000
Q2 2022

Jul 11, 2022

SELL
$137.62 - $174.96 $825 - $1,049
-6 Reduced 0.24%
2,541 $391,000
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $1,583 - $1,965
12 Added 0.47%
2,547 $412,000
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $1,396 - $1,767
13 Added 0.52%
2,535 $343,000
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $12,023 - $13,648
113 Added 4.69%
2,522 $274,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $11,678 - $13,010
111 Added 4.83%
2,409 $277,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $21,380 - $23,537
209 Added 10.0%
2,298 $264,000
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $168,143 - $227,011
2,089 New
2,089 $235,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Management Network Inc Portfolio

Follow Financial Management Network Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Network Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Network Inc with notifications on news.